Sania Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$5M
- Investors
-
7
Sania Therapeutics General Information
Description
Developer of gene therapies intended to improve the quality of life of people with neurological diseases. The company uses virology, molecular biology, and bioinformatics to build therapies that are precisely targeted to neural circuits by delivering genetic material to infected cells, enabling healthcare providers to cure neurological disorders effectively.
Contact Information
Website
www.saniarx.comCorporate Office
- Waterfront building
- Manbre Road
- London W6 9RH
- England, United Kingdom
Corporate Office
- Waterfront building
- Manbre Road
- London W6 9RH
- England, United Kingdom
Sania Therapeutics Timeline
Sania Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 06-May-2024 | $5M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 01-May-2024 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Mar-2023 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 18-Mar-2022 | $5.05M | $5.05M | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2021 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sania Therapeutics Patents
Sania Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202502500-D0 | Method | Inactive | 20-Feb-2025 | ||
| GB-202416499-D0 | Method | Pending | 08-Nov-2024 | ||
| GB-202416503-D0 | Method | Pending | 08-Nov-2024 | ||
| GB-202416507-D0 | Method | Pending | 08-Nov-2024 | ||
| GB-202406331-D0 | Capsid | Inactive | 07-May-2024 | C07K14/005 |
Sania Therapeutics Signals
Sania Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Harbrook | Corporation | Minority | ||
| SCI Ventures (London) | Venture Capital | Minority | ||
| Grow London | Accelerator/Incubator | |||
| Arc Ventures (United States) | Venture Capital | Minority | ||
| Axial (San Francisco) | Venture Capital | Minority |
Sania Therapeutics FAQs
-
When was Sania Therapeutics founded?
Sania Therapeutics was founded in 2021.
-
Where is Sania Therapeutics headquartered?
Sania Therapeutics is headquartered in London, United Kingdom.
-
What is the size of Sania Therapeutics?
Sania Therapeutics has 15 total employees.
-
What industry is Sania Therapeutics in?
Sania Therapeutics’s primary industry is Drug Discovery.
-
Is Sania Therapeutics a private or public company?
Sania Therapeutics is a Private company.
-
What is Sania Therapeutics’s current revenue?
The current revenue for Sania Therapeutics is .
-
How much funding has Sania Therapeutics raised over time?
Sania Therapeutics has raised $11.5M.
-
Who are Sania Therapeutics’s investors?
Harbrook, SCI Ventures (London), Grow London, Arc Ventures (United States), and Axial (San Francisco) are 5 of 7 investors who have invested in Sania Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process